Truist Securities Reiterates Buy Rating on Legend Biotech Corp. (LEGN): "infer from comments that Raritan's full manufacturing slot capacity approved"

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/2/2026

1. SPY
2. META
3. TSLA
4. STZ
5. GOOGL
6. HOOD
7. FDS
8. NVDA
9. FUTU
10. CSGP

Go back to Truist Securities Reiterates Buy Rating on Legend Biotech Corp. (LEGN): "infer from comments that Raritan's full manufacturing slot capacity approved"
(NASDAQ: LEGN) Delayed: 30.02 +0.13 (0.43%)
Previous Close $29.89    52 Week High $ 
Open $30.07    52 Week Low $ 
Day High $30.27    P/E N/A 
Day Low $29.68    EPS $ 
Volume 563,308